NCT01814904View on ClinicalTrials.gov

Dose-finding Study of MCI-196

PHASE3TerminatedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Chronic Kidney DiseaseDialysisHyperphosphatemiaPaediatric
Interventions
DRUG

colestilan-L

body surface area equivalent (BSAeq) 3 g/day

DRUG

colestilan-M

BSAeq 6 g/day

DRUG

colestilan-H

BSAeq 9 g/day

DRUG

CBPB

Trial Locations (1)

Unknown

Investigational site, London

Sponsors
All Listed Sponsors
lead

Mitsubishi Tanabe Pharma Corporation

INDUSTRY